AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland

AstraZeneca has signed a deal with the Switzerland FOPH to deliver over 1,200 doses of tixagevimab and cilgavimab combination for Covid-19.

Related Keywords

Switzerland ,Swiss ,Astrazeneca ,Astrazeneca Evusheld ,Vanderbilt University Medical Center ,Swiss Society Of Infectious Diseases ,European Commission ,Services For Pharmaceuticals ,Research Tools For Pharmaceutical Developers ,Cell Mediated Immune Monitoring For Research ,Office Of Public Health ,Creative Commons ,Federal Office ,Public Health ,Swiss Society ,Infectious Diseases ,Zeneca Switzerland ,Katrien De Vos ,Finish Services ,Mediated Immune Monitoring ,Research Tools ,